Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II) - European Urology
JCI - The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans
Overactive Bladder Drug Gains Pediatric Indication | MedPage Today
Mechanism of Action | MYRBETRIQ® (mirabegron ER tablets)
Mirabegron is alternative to antimuscarinic agents for overactive bladder without higher risk in hypertension: a systematic review and meta-analysis | Semantic Scholar
Current Management of OAB - ppt download
Gary Leach on Twitter: "Giving informative lecture on overactive bladder at Fleming's in El Segundo!! @GaryLeachMD @TowerUrology https://t.co/d893O9Z6oe" / Twitter
Myrbetriq (Mirabegron) - Treatment for Overactive Bladder (OAB) - Clinical Trials Arena
Mirabegron: potential off target effects and uses beyond the bladder - Dehvari - 2018 - British Journal of Pharmacology - Wiley Online Library
The β3‐adrenoceptor agonist mirabegron increases human atrial force through β1‐adrenoceptors: an indirect mechanism? - Mo - 2017 - British Journal of Pharmacology - Wiley Online Library
Twitter 上的 IMChiefs："Urinary incontinence plagues many of our elderly patients, but many of us may not be familiar with meds outside of anti-cholinergics. This slide demonstrates MOA of selective B3 agonists, a
A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder - Urology
β3-Receptor Agonists for Overactive Bladder—New Frontier or More of the Same? | SpringerLink
MOA for Combination Treatment | MYRBETRIQ® (mirabegron ER tablets)
Mirabegron: potential off target effects and uses beyond the bladder - Dehvari - 2018 - British Journal of Pharmacology - Wiley Online Library
Myrbetriq (Mirabegron): Uses, Dosage, Side Effects, Interactions, Warning
Mirabegron induces relaxant effects via cAMP signaling‐dependent and ‐independent pathways in detrusor smooth muscle - Maki - 2019 - LUTS: Lower Urinary Tract Symptoms - Wiley Online Library
Mirabegron: potential off target effects and uses beyond the bladder. - Abstract - Europe PMC
Mirabegron monotherapy trials adjusted mean change from baseline to end... | Download Scientific Diagram
Beyond Antimuscarinics: A Review of Pharmacological and Interventional Options for Overactive Bladder Management in Men - European Urology
Updating the evidence on drugs to treat overactive bladder: a systematic review | SpringerLink
Efficacy and safety of Mirabegron as adjuvant treatment in children with refractory neurogenic bladder dysfunction - Journal of Pediatric Urology
